spacer
home > white papers > Managing GxP Environmental Systems to Ensure Data Integrity - Vaisala Ltd
WHITE PAPERS
logo_Vaisala_LtC.JPG

Vaisala Ltd

phone +358 50 364 4909
email marina.stenfors@vaisala.com
web http://www.vaisala.com
email Bury St Edmunds Office, Unit 2b Hillside Business Park, Kempson Way, Bury St Edmunds, Suffolk, IP32 7EA

Managing GxP Environmental Systems to Ensure Data Integrity

In this paper, we provide some history of data management for life science systems and an overview of new regulatory expectations, including changes to guidance. We then offer eight recommendations for establishing and maintaining good practices for data integrity.
Managing GxP Environmental Systems to Ensure Data Integrity
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Bioclinica Moves to New Princeton, New Jersey Office in Response to Growth


More info >>


White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>


Industry Events

BIO-Europe® 2017

6-8 November 2017, Messedamm 26 14055 Berlin Germany

The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement